How many injections in nAMD: ranibizumab vs. aflibercept
1 April 2017
| Eulee Seow
|
Retina / Uvea / Vitreous
|
aflibercept, clinical practice, neovascular age-related macular degeneration, ranibizumab, visual acuity
Intravitreal anti-VEGF injections make up a large proportion of the workload in ophthalmology clinics. Since the introduction of aflibercept with eight weekly injections there has been an option to use a treatment which may require less treatment, with potential cost...
